Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117409) titled 'Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure' on Aug. 5.

Study Type: Observational

Primary Sponsor: Azienda USL Reggio Emilia - IRCCS

Condition: Metastatic Renal Cell Carcinoma

Recruitment Status: Not recruiting

Date of First Enrollment: June 29, 2020

Target Sample Size: 81

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117409

Published by HT Digital Content Services with permission from Health Daily Digest....